item management s discussion and analysis of financial condition and results of operation results of operations compared with the company reported net income of  or per share in as compared to net income of  or 
per share in all per share amounts have been restated to give effect to a stock dividend paid on march  to stockholders of record as of february  the increase in net income in is attributable to a increase in net sales which is primarily related to increases in volume of products sold and not to increases in prices  while operating expenses increased only 
another significant factor is that there were no legal settlement costs incurred during the positive factors are mitigated to an extent by an increase in the effective income tax rate to in from in net sales increased by  to  in as compared to  in chemical s sales increased by approximately  in as compared to  of this increase was due to an increase in the sales of bidrin r 
in december the appropriate permitting was finally obtained and the company began manufacturing bidrin r 
the late start in manufacturing resulted in reduced sales of bidrin r in  however the latent demand was satisfied in the first half of resulting in strong bidrin r sales in the first and second quarters of sales of bidrin r in the fourth quarter were significantly higher than the fourth quarter during chemical was also able to generate significant sales increases in its pcnb products of  to  as compared to  in and naled products of  to  from  in however  these increases were substantially offset by a decrease in the sales of phosdrin r in the amount of  to  in from  in as a result of agreements reached with the environmental protection agency epa during  the company agreed to phaseout the domestic distribution  sale and use of phosdrin r 
although the effective date of the cessation of phosdrin r use domestically was november   domestic sales of phosdrin r began to drop off significantly beginning in july essentially all of the phosdrin r sales in were export sales 
the remaining change in chemical s sales was attributable to less significant changes in the sales mix of chemical s products 
gemchem s sales after elimination of intercompany sales declined from approximately  in to approximately  in reflecting competition in gemchem s non ag markets 
gross profits increased by  to  in as compared to  the increase in is a result of the higher volume of sales in the gross profit percentage increased to in from in while the phaseout of phosdrin r  a very profitable product  had a negative impact on gross profit in  the overall gross profit percentage increased as the sales volume increased proportionately higher than cost of sales 
operating expenses increased by  to  in from  in the following is a discussion of operating expenses selling and regulatory selling and regulatory expenses increased by  to  in from  in the increase in selling and regulatory expenses is primarily attributable to an increase in variable selling costs 
due to the significant increase in bidrin r sales in  related bidrin r rebates and royalties increased by approximately  rebates and royalties on naa products increased approximately  in primarily as a result of agreements with distributors to promote the company s products in the market 
expenses of gemchem increased approximately  in product liability insurance  which varies directly with sales levels  also increased approximately  in as a result of the increased sales volume 
the only significant decrease in selling and regulatory costs was attributable to a  decline in phosdrin r related rebates which was a result of the phase out of phosdrin r 
research and development research and development costs  which include costs incurred to generate scientific data and other activities performed in the department  decreased by  to  in from  in costs incurred to generate scientific data decreased by  to  in as compared to  in the largest reduction in scientific data generation was in connection with phosdrin r 
due to the phase out of phosdrin r as discussed above  data generation costs with respect to phosdrin r decreased approximately  in to approximately  the naa  ddvp and pcnb product groups also experienced significant declines in scientific data generation of approximately   and  respectively  in due to the maturation of the products and of the related research studies being conducted 
bidrin r  which is a relatively recent addition to chemical s product line  was the only major product group to experience an increase in scientific data generation in bidrin r scientific data generation costs increased approximately  in in the company received a benefit of  as a result of an unrelated chemical company paying the company for the right to cite and rely upon data developed by the company 
the company did not receive any benefits of this kind in freight  delivery and warehousing freight  delivery and warehousing costs increased by  to  in from  in the increase in costs is primarily due to increased freight costs as a result of the higher sales at chemical and additions to shipping department personnel to handle the additional demand 
general  administrative and corporate general  administrative and corporate costs increased by  to  in from  in the increase was primarily attributable to environmental consulting projects and legal fees which accounted for approximately  additionally  the company elected to provide for the remaining expected costs in connection with the phase out of phosdrin r in the amount of  interest costs were  in as compared to  in the average level of short term borrowing decreased by  to  in from  in the average level of long term debt declined by  to  in from  in the reduction in the average debt and the change in effective interest rates accounted for the decrease in interest costs in income tax expense increased by  to  in as compared to  in higher pre tax income combined with lower tax credits are the reason for the increased income tax expense 
see note to the consolidated financial statements for additional analysis of the changes in income tax expense 
weather patterns can have an impact on the company s operations 
weather conditions influence pest population by impacting gestation cycles for particular pests and the effectiveness of some of the company s products  among other factors 
the company manufactures and formulates chemicals for crops  human and animal health protection 
the end user of some of the company s products may  because of weather patterns  delay or intermittently disrupt field work during the planting season which may result in a reduction of the use of some of the company s products 
because of elements inherent to the company s business  such as differing and unpredictable weather patterns  crop growing cycles  changes in product mix of sales and ordering patterns that may vary in timing  measuring the company s performance on a quarterly basis  gross profit margins on a quarterly basis may vary significantly even when such comparisons are favorable  is not as good an indicator as full year comparisons 
compared with the company reported net income of  or 
per share in as compared to net income of  or 
per share in significant factors adversely affecting net income in include provisions for settlements of legal matters in the amount of  refer to part i  item of this annual report  a reduction in gross profits from of approximately  and an increase in interest expense of approximately  partially offsetting these negative factors were a decrease in operating expenses of approximately  as well as a decrease in income tax expense of approximately  net sales declined by  to  in as compared to  chemical s sales declined by approximately  in as compared to this decline was primarily due to a reduction in the sales of bidrin r 
in november  chemical purchased from du pont  the rights  title and interest in bidrin r  an insecticide for cotton crops 
concurrently with the purchase of the rights to bidrin r  chemical purchased du pont s existing inventory at du pont s approximate cost and sold that inventory in chemical did not begin manufacturing bidrin r until december  when the required permitting was granted 
as a result  product delivered in was significantly less than in the decline in chemical s sales was essentially offset by an increase in sales as a result of the company s acquisition of gemchem in mid january gemchem s sales in  after it was acquired by the company were approximately  the remaining change in sales was attributable to changes in the sales mix of the company s products 
gross profits declined by  to  in as compared to  in this represents a decline in the gross profit margin of approximately 
this decline was primarily due to the impact of gemchem sales on consolidated gross profit 
gemchem  in addition to being the exclusive sales agent for the company  is also a distributor of various pharmaceutical and nutritional supplement products 
the gross profit margin for the distribution of gemchem s products was approximately compared to the gross profit margin of approximately for the company s manufactured products 
operating expenses declined by  to  in from the  reported in the following is a discussion of operating expenses selling and regulatory selling and regulatory expenses decreased by  to  in from  in the decrease in selling and regulatory expenses is primarily attributable to a decrease in variable selling costs 
significant reductions in bidrin r rebates and royalties of approximately  occurred as a result of the lower sales of bidrin r in additionally  a royalty contract related to sales of phosdrin r expired at the end of eliminating royalties of approximately  incurred in other reductions in rebates as a result of changes in the sales mix amounted to approximately research and development research and development costs  which include costs incurred to generate scientific data and other activities performed in the department  increased by  to  in from  in costs incurred to generate scientific data increased by  to  in as compared to  in the most significant increases in scientific data generation related to the bidrin r and napthalene acetic acid product groups which accounted for an increase in costs of approximately  while a gradual curtailment of costs related to the ddvp product group resulted in a reduction in costs in of approximately  the company did receive a benefit of  in as a result of an unrelated chemical company paying the company for the right to cite and rely upon data developed by the company 
freight  delivery and warehousing freight  delivery and warehousing costs decreased by  to  in from  in these costs decreased primarily as a result of decreased freight costs due to lower sales at chemical 
general  administrative and corporate general  administrative and corporate costs increased by  to  in from  in the increase was primarily attributable to an increase in legal costs 
refer to part i  item for a discussion of legal proceedings 
interest costs were  in as compared to  in the average level of short term borrowing increased by  to  in from  in the average level of long term debt declined by  to  in from  in the lower average debt for as compared to  was not sufficient to offset higher effective interest rates which accounted for the increase in interest costs 
income tax expense decreased by  to  in as compared to  in see note to the consolidated financial statements for an analysis of the changes in income tax expense 
liquidity and capital resources working capital was  as of december  reflecting an  improvement over working capital of  as of december  current assets were  higher at december  than at december  while trade receivables were  higher at december  due to the greater sales volume at chemical  the increase was substantially offset by the payment in of a  legal settlement receivable recorded at december  related to the dbcp settlement refer to part i  item  legal proceedings and note of the notes to the consolidated financial statements of this annual report for additional information 
also offsetting the increase in trade receivables was a decrease in other receivables of  which was primarily attributable to the receipt of  related to the sale of rights to the use of scientific data generated by the company 
inventories increased  in over the higher inventory level is attributable to a planned build up of certain of the company s finished products in anticipation of meeting future sales demands 
prepaid expenses decreased  in which was primarily due to the expense recognition of royalties paid in advance 
current liabilities decreased  in over the company paid down the company s fully secured line of credit from  at december  to  at december  additionally  in september  the company renewed and amended its line of credit agreement with its bank  one of the terms of which was the extension of the expiration date to july  as such  the balance of  under the line of credit agreement at december  has been classified as a long term liability 
the line of credit agreement  which has a borrowing limit of  had  of available credit at december  another significant reduction in current liabilities as of december  was the payment during of a legal settlement in the amount of  related to the dbcp lawsuits refer to part i  item  legal proceedings and note of the notes to the consolidated financial statements of this annual report for additional information 
the effects of the above noted decreases were offset by an increase in income taxes payable of  and a net increase in accounts payable and other accrued expenses of the company invested  in capital expenditures in these expenditures improve and or maintain the existing capacity of the company s manufacturing facility  and address the company s continual effort to adapt its manufacturing processes to the environmental control standards of its various controlling agencies 
the company also invested  in deferred charges in  most of which relate to epa study costs 
the capitalized balance of deferred charges as of december  are not material 
the company recognized  of depreciation and amortization expense in as of december   the company does not have any material commitments for future capital expenditures 
as part of the renewal and amendment of the company s credit facility  as discussed above  the company increased its term loan availability to a maximum of  to be paid in monthly installments through december  the company borrowed an additional  in december which increased the existing term loan to the maximum amount allowed as of december  the company made principal payments on its long term debt of  during there has been constant public pressure upon the federal and state governments to require fifra product registrants to supply new scientific data such as toxicological and environmental fate tests  which has resulted in government action requiring additional studies and the submission of more data 
based on facts known today  the company estimates it will spend approximately  in on these studies 
because scientific analyses are constantly improving  it cannot be determined with certainty whether or not material new or additional tests may be required 
additionally  while fifra good laboratory practice standards specify the minimum practices and procedures which must be followed in order to ensure the quality and integrity of data related to these tests submitted to the epa  there can be no assurance the epa will not request certain tests studies be repeated 
for further information  refer to part i  item  business  competition of this annual report 
chemical is a manufacturer and formulator of chemicals for crops  human and animal health protection 
for discussions pertaining to the company s litigation refer to part i  item  legal proceedings of this annual report 
management believes current financial resources working capital and borrowing arrangements and anticipated funds from operations will be adequate to meet total financial needs in management also continues to believe  to improve its working capital position and maintain flexibility in financing interim needs  it is prudent to explore alternate sources of financing 
the company  as previously disclosed  is required to supply studies and the submission of data to federal and state governmental agencies 
because scientific analyses are constantly improving  it cannot be determined with certainty whether or not additional tests that may be material will be required 
although management does not currently foresee any critical liquidity problems  should material new or additional tests be required during  anticipated funds from operations may not be adequate to meet total financial needs in management believes that inflation has not had a significant impact on the company s costs and prices during the past three years 
new accounting standards statement of financial accounting standards no 
 accounting for the impairment of long lived assets and for long lived assets to be disposed of sfas no 
issued by the financial accounting standards board fasb is effective for financial statements for fiscal years beginning after december  the new standard establishes guidelines regarding when impairment losses on long lived assets  which include plant and equipment  and certain identifiable intangible assets  should be recognized and how impairment losses should be measured 
the company does not expect adoption to have a material effect on its financial position or results of operations 
statements of financial accounting standards no 
 accounting for the stock based compensation sfas no 
issued by the fasb is effective for specific transactions entered into after december   while the disclosure requirements of sfas no 
are effective for financial statements for fiscal years beginning no later than december  the new standard establishes a fair value method of accounting for stock based compensation plans and for transactions in which an entity acquires goods or services from non employees in exchange for equity instruments 
the company does not expect adoption to have a material effect on its financial position or results of operations 
at the present time  the company has not determined if it will change its accounting policy for stock based compensation or only provide the required financial statement disclosures 
as such  the impact on the company s financial position and results of operations is currently unknown 

